
Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells
Keywords: In vitro toxicity testing; hESC-derived cardiomyocytes; Doxorubicin; Biosensors; Surface plasmon resonance, SPR